Patents by Inventor H. William Strauss
H. William Strauss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10201623Abstract: The present invention provides new methods for cardiac imaging and related medical applications thereof. In some embodiments, the present invention provides a method for the diagnosis of cardiovascular diseases, conditions, or disorders. In some embodiments, the present invention provides a method for the treatment or prevention of cardiovascular diseases, conditions, or disorders. In some embodiments, the present invention provides methods for monitoring the effect of cancer treatment on the heart, and/or methods for monitoring a cancer treatment regimen. In some embodiments, the present invention provides a method for selecting subjects for a test or treatment. In some embodiments, the present invention provides a method for determining the dosage of a drug. In some embodiments, the present invention provides methods for determining the risk of a cardiovascular disease, for assessing risk of a cardiovascular disease, and/or for determining the risk of heart attack.Type: GrantFiled: March 14, 2014Date of Patent: February 12, 2019Assignee: Memorial Sloan Kettering Cancer CenterInventors: Mark Dunphy, H. William Strauss, Gabriela Chiosis
-
Publication number: 20160015837Abstract: The present invention provides new methods for cardiac imaging and related medical applications thereof. In some embodiments, the present invention provides a method for the diagnosis of cardiovascular diseases, conditions, or disorders. In some embodiments, the present invention provides a method for the treatment or prevention of cardiovascular diseases, conditions, or disorders. In some embodiments, the present invention provides methods for monitoring the effect of cancer treatment on the heart, and/or methods for monitoring a cancer treatment regimen. In some embodiments, the present invention provides a method for selecting subjects for a test or treatment. In some embodiments, the present invention provides a method for determining the dosage of a drug. In some embodiments, the present invention provides methods for determining the risk of a cardiovascular disease, for assessing risk of a cardiovascular disease, and/or for determining the risk of heart attack.Type: ApplicationFiled: March 14, 2014Publication date: January 21, 2016Inventors: Mark DUNPHY, H. William STRAUSS, Gabriela CHIOSIS
-
Patent number: 7666389Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described.Type: GrantFiled: November 15, 2007Date of Patent: February 23, 2010Assignees: The Board of Trustees of the Leland Stanford Junior University, University of WashingtonInventors: Francis G. Blankenberg, Peter D. Katsikis, H. William Strauss, Jonathan F. Tait
-
Publication number: 20080138279Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described.Type: ApplicationFiled: November 15, 2007Publication date: June 12, 2008Applicants: The Board of Trustees of the Leland Stanford Junior University, University of WashingtonInventors: Francis G. Blankenberg, H. William Strauss, Jonathan F. Tait, Peter D. Katsikis
-
Publication number: 20040170603Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described. Methods for tumor radiotherapy are also provided.Type: ApplicationFiled: March 5, 2004Publication date: September 2, 2004Applicants: The Board of Trustees of the Leland Stanford Junior University, Theseus Imaging CorporationInventors: H. William Strauss, Francis G. Blankenberg, Allan M. Green, Neil Steinmetz
-
Patent number: 6782289Abstract: Methods, devices, and kits, for assessing luminal lesions are provided. The subject devices comprise an intraluminal detector capable of sensing radioactive or other labels. In the subject methods, a detectable marker is introduced to a body lumen, either into the lumen itself or systemically in patient circulation, and localizes at a lesion. The detector is introduced into the body lumen and the distribution of a localized marker detected in situ. The information is useful for a number of purposes including the identification of unstable plaque in patients suffering from atherosclerotic disease.Type: GrantFiled: September 26, 2000Date of Patent: August 24, 2004Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventor: H. William Strauss
-
Patent number: 6726895Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described. Methods for tumor radiotherapy are also provided.Type: GrantFiled: April 3, 2002Date of Patent: April 27, 2004Assignees: Board of Trustees of the Leland Stanford Junior University, Theseus Imaging CorporationInventors: H. William Strauss, Francis G. Blankenberg, Allan M. Green, Neil Steinmetz
-
Publication number: 20030152513Abstract: The present invention relies on the affinity of stressed or apoptotic cells for exogenously administered annexin V to create a multi-functional molecular probe that can be simultaneously used for imaging (localization of unstable plaque within the body) and therapy (treatment of unstable plaque).Type: ApplicationFiled: September 6, 2002Publication date: August 14, 2003Applicant: IMETRIX, INC.Inventors: Francis G. Blankenberg, Jagat Narula, H. William Strauss, Vartan Ghazarossian
-
Publication number: 20030036699Abstract: Methods, devices, and kits, for assessing luminal lesions rely on intraluminal detection of labeled annexin. Annexin coupled to a detectable marker is introduced to a body lumen, either into the lumen itself or systemically in patient circulation, and localizes at a lesion. The detector is introduced into the body lumen and the localize distribution of the detectable marker is detected in situ. The information is useful for a number of purposes including the identification of unstable plaque in patients suffering from atherosclerotic disease.Type: ApplicationFiled: February 21, 2002Publication date: February 20, 2003Applicant: IMETRx, Inc.Inventor: H. William Strauss
-
Publication number: 20020115931Abstract: Methods and systems for localizing intravascular lesion in a body lumen. In exemplary embodiments, the methods comprise providing or acquiring an image of the body lumen and displaying information about the lesion with or on the image. In some configurations the information is obtained with an intravascular catheter.Type: ApplicationFiled: February 21, 2001Publication date: August 22, 2002Inventors: H. William Strauss, Leon Kaufman, Vartan Ghazarossian
-
Patent number: 6197278Abstract: A method of imaging apoptosis in vivo, using radiolabeled annexin, is described.Type: GrantFiled: April 29, 1998Date of Patent: March 6, 2001Assignees: The Board of Trustees of the Leland Stanford Junior University, University of WashingtonInventors: Francis G. Blankenberg, H. William Strauss, Jonathan F. Tait, Peter D. Katsikis
-
Patent number: 5792444Abstract: The invention relates to a method of detecting a site of infection or inflammation, and a method for treating such infection or inflammation, in an individual by administering to the individual a diagnostically or therapeutically effective amount of detectably labeled, therapeutic, or therapeutically-conjugated, chemotactic peptide that accumulates substantially at the infected or inflamed site, said chemotactic peptide having the general structureX--Y--Leu--Phe--?Z!.sub.n --Wwherein:X is an amino protecting group,Y is an amino acid residue,Z is a spacer sequence,n is 0 or 1, andW is a labeling or attachment substituent.Type: GrantFiled: October 22, 1993Date of Patent: August 11, 1998Assignees: The General Hospital Corporation, Johnson Matthey, Inc., Ortho Pharmaceutical CorporationInventors: Alan J. Fischman, Howard F. Solomon, Claudia K. Derian, Gary J. Bridger, John D. Higgins, III, Scott K. Larsen, Pedro E. Hernandez, Robert H. Rubin, H. William Strauss, Anthony J. Fuccello, Daniel J. Kroon
-
Patent number: 5363846Abstract: The invention relates to a method of detecting an inflammation site in an individual by administering to the individual a diagnostically effective amount of detectably labeled immunoglobulin or fragment thereof, wherein the immunoglobulin substantially accumulates at the site when the site is inflamed.Type: GrantFiled: May 21, 1990Date of Patent: November 15, 1994Assignee: The General Hospital CorporationInventors: Robert H. Rubin, H. William Strauss
-
Patent number: 5277894Abstract: The invention relates to a method of detecting an Fc receptor-expressing tumor site in an individual by administering to the individual a diagnostically effective amount of detectably-labeled non-specific immunoglobulin or Fc or Fc' fragment thereof, wherein the immunoprotein substantially accumulates at the site when the site bears such a tumor. By using a therapeutically-labeled specific or non-specific immunoglobulin or Fc or Fc' fragment thereof, the tumor may be treated therapeutically.Type: GrantFiled: February 25, 1993Date of Patent: January 11, 1994Assignee: The General Hospital CorporationInventors: H. William Strauss, Robert H. Rubin, Ban A. Khaw, Faina Shtern
-
Patent number: 5200178Abstract: The invention relates to a method of detecting an Fc receptor-expressing tumor site in an individual by administering to the individual a diagnostically effective amount of detectably-labeled non-specific immunoglobulin or Fc or Fc' fragment thereof, wherein the immunoprotein substantially accumulates at the site when the site bears such a tumor. By using a therapeutically-labeled specific or non-specific immunoglobulin or Fc or Fc' fragment thereof, the tumor may be treated therapeutically.Type: GrantFiled: July 16, 1991Date of Patent: April 6, 1993Assignee: The General Hospital CorporationInventors: H. William Strauss, Robert H. Rubin, Ban An Khaw, Faina Shtern
-
Patent number: 4952393Abstract: Method using technetium-99m imaging agents for the study, detection or diagnosis of ischemic, infarcted or diseased tissue. The imaging agents comprise a complex of technetium-99 m and glucarate.Type: GrantFiled: October 7, 1988Date of Patent: August 28, 1990Assignee: The General Hospital CorporationInventors: Harvey J. Berger, Ban A. Khaw, Koon Y. Pak, H. William Strauss
-
Patent number: 4926869Abstract: The invention relates to a method of detecting an inflammation site in an individual by administering to the individual a diagnostically effective amount of detectably labeled immunoglobulin or fragment thereof, wherein the immunoglobulin substantially accumulates at the site when the site is inflamed.Type: GrantFiled: November 13, 1987Date of Patent: May 22, 1990Assignee: The General Hospital CorporationInventors: Robert H. Rubin, H. William Strauss
-
Patent number: 4633881Abstract: An ambulatory ventricular function anaylzer system is provided. The ambulatory ventricular function analyzer system is carried by a garment worn by a cardiac patient and includes ECG electrodes, a main left ventricular probe detector, and a background lung probe detector for providing diagnostically useful information while the patient goes about the normal activities of daily life. An information processing sub-system including a microprocessor responds to the electrode signal and to the probe signals and provides composite data representative of the ECG activity, the background lung time-activity, the left ventricular time-activity, and an R-wave histogram averaged over multiple cardiac cycles.Type: GrantFiled: July 1, 1982Date of Patent: January 6, 1987Assignee: The General Hospital CorporationInventors: Richard H. Moore, H. William Strauss, Nathaniel M. Alpert
-
Patent number: 4572197Abstract: A vest for positioning medical instrumentation about the human or animal torso to provide ambulatory monitoring of patient cardiac functions or administration of medication or therapy with reasonable freedom of movement while maintaining precise positioning of the instrumentation relative to the torso. The vest functions to provide accurate placement of such instrumentation as a radioactive emission sensor for monitoring ejection fraction. The vest typically includes a sheet of a dimensionally rigid material such as a low density polymer tailored to fit between neck and hips and to surround the torso, terminating on the back. Straps are provided to fasten the sheet ends together at the back and to suspend it from the shoulders. The vest may also be instrumented to function as a transducer itself to detect chest expansion for heart beat or lung volume monitoring.Type: GrantFiled: June 1, 1984Date of Patent: February 25, 1986Assignee: The General Hospital CorporationInventors: Richard H. Moore, H. William Strauss, Nathaniel M. Alpert
-
Patent number: RE35152Abstract: The invention relates to a method of detecting an inflammation site in an individual by administering to the individual a diagnostically effective amount of detectably labeled immunoglobulin or fragment thereof, wherein the immunoglobulin substantially accumulates at the site when the site is inflamed.Type: GrantFiled: May 20, 1992Date of Patent: February 6, 1996Assignee: The General Hospital CorporationInventors: Robert H. Rubin, H. William Strauss